Show Stocks and Investing Publications • Fri, November 11, 2022
Yatin Suneja Maintained (AXSM) at Strong Buy with Increased Target to $80 on, Nov 11th, 2022
ntained-axsm-at-strong-buy-with-increased-target-to-80-on-nov-11th-2022.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIYatin Suneja of Guggenheim, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $72 to $80 on, Nov 11th, 2022.
Yatin has made no other calls on AXSM in the last 4 months.
There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 1 agrees with Yatin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $73 on, Tuesday, November 8th, 2022
These are the ratings of the 5 analyists that currently disagree with Yatin
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Wednesday, November 9th, 2022
- Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
- Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
Like: 👍